Skip to main content
Equibles

Squarepoint Ops LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1642575 NEW YORK, NY
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$502,369
+$218,405 QoQ
Shares Held
241,524
+107.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 209 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. ALLO ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in ALLO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $502,369 241,524
2026-03-31 $283,964 116,379
2025-12-31 $143,378 104,656
2025-09-30 $332,374 268,044
2025-06-30 $20,414 18,066
2025-03-31 $476,726 326,525
2024-12-31 $43,334 20,345
2024-09-30 $527,791 188,497
2024-06-30 $295,043 126,628
2023-09-30 $386,080 121,792
2023-06-30 $248,186 49,937
2023-03-31 $280,468 56,775
2022-12-31 $1,260,289 200,364
2022-09-30 $2,660,277 246,322
2022-03-31 $2,453,505 269,320
2020-12-31 $398,590 15,792
2020-09-30 $222,489 5,900